Source: International Congress 2016 – What's new in biomarker analysis?
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Andreina Bruno (Palermo, Italy), Andreina Bruno, Antonella Ballacchino, Liboria Siena, Domenica Russo, Salvatore Gallina, Francesco Lorusso, Giuseppina Chiappara, Mark Gjomarkaj, Elisabetta Pace. Impairment of leptin/leptin receptor pathway in nasal epithelium from allergic turbinates. Eur Respir J 2016; 48: Suppl. 60, 905

Member's Comments

No comment yet.

Related content which might interest you: Expression of eotaxins in nasal mucosa of allergic patients after intranasal provocation- preliminary study Source: Annual Congress 2013 –Cell biology and murine models of asthma and inflammation Year: 2013 Distribution of mast cells and their interactions with nerve in allergic rhinitis Source: International Congress 2015 – Asthma and lung immunology Year: 2015 Fluticasone furoate maintains epithelial homeostasis via leptin/leptin receptor pathway in nasal cells Source: Annual Congress 2013 –Cell signalling and inflammation: what's new in 2013? Year: 2013 RV-infection modifies DNA-methylation in nasal airway epithelium cell line: Evaluation as a possible asthma trigger Source: International Congress 2014 – Paediatric asthma: pathogenesis and immunology Year: 2014 Intranasal GSK2245035 induces prolonged reductions in nasal responsiveness to allergen Source: International Congress 2015 – The immunology of allergic airway disease Year: 2015 IgE plasma level in asthmatics with nasal polyps is independent of atopy Source: International Congress 2016 – Laboratory tests and cell biology in allergy and immunology Year: 2016 Role of IL-33/ST2 axis in systemic inflammation of allergic airway disease Source: International Congress 2014 – New mechanisms in the pathogenesis of asthma and other lung diseases Year: 2014 Beta2 adrenergic agonist attenuates house dust mite-induced allergic airway inflammation in mice Source: International Congress 2014 – Mechanistic murine studies of asthma and lung inflammation Year: 2014 H4 receptor antagonits as a potential medication for upper airway cough syndrom Source: International Congress 2014 – New treatments for cough, asthma, COPD and ILDs Year: 2014 Airway remodeling and eosinophilic asthma Source: Annual Congress 2013 –Cell biology and murine models of asthma and inflammation Year: 2013 Discrimination of bronchial inflammatory phenotype of asthmatic patients by using the electronic nose Source: Annual Congress 2013 –Origins and diagnosis of asthma Year: 2013 QAV680, cetirizine and their combination reduce nasal symptoms in patients with intermittent allergic rhinitis in an environmental exposure chamber Source: International Congress 2014 – Allergy and asthma: novel findings based on human cell biology Year: 2014 Association between Type 2 innate lymphoid cells increasement and allergy in patients with chronic rhinosinusitis and asthma Source: International Congress 2016 – Laboratory tests and cell biology in allergy and immunology Year: 2016 HMGB1 expression and function in the allergic airway immune response Source: International Congress 2014 – Exploring molecular mechanisms of allergy and asthma in animal models Year: 2014 Pim1 kinase affects allergic asthma in a HDM-driven mice model Source: International Congress 2014 – Mechanistic murine studies of asthma and lung inflammation Year: 2014 Relationship between airway inflammation and bronchial responsiveness in children with and without asthma Source: International Congress 2014 – Paediatric asthma: lung function testing and more Year: 2014 Inhibitory effects of montelukast on mediator release by nasal epithelial cells from asthmatic subjects Source: Annual Congress 2013 –The pulmonary epithelium: recent developments Year: 2013 LATE-BREAKING ABSTRACT: Inhibition of TRPA1 reduces airway inflammation and airway hyper-responsiveness in a murine model of allergic rhinitis Source: International Congress 2016 – Novel mechanisms and therapeutic targets in acute and chronic inflammatory disease Year: 2016 LATE-BREAKING ABSTRACT: Effects of a dual CysLT1/2 antagonist, ONO-6950, on allergen-induced airway responses in subjects with mild allergic asthma. Source: International Congress 2014 – Latest insights in airway diseases Year: 2014 Allergic and non-allergic childhood asthma is characterized by novel biomarkers and signaling pathways Source: International Congress 2014 – Paediatric asthma: markers and molecules Year: 2014